13F filer · CIK 1562230 ↗
Capital International Investors
You are looking at Q3 2020. See the latest, Q2 2026 →
Reported value
$323.46B
+6.0% on the quarter before
Positions
435
41 new · 19 sold out
Top 10
30.4%
of the value
Est. gain
+$16.26B
on stocks held all quarter
Est. return
+5.8%
on those stocks since Q2 2020
Positions as of Sep 30, 2020, from Capital International Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 45% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2020. Striped tiles are options.
Largest buys
Since Q2 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Fidelity Natl Information Sv~$2.41BNew · 0.0% → 0.7%+16,372,621 shares
- Mastercard~$1.77BAdded · 0.3% → 0.9%+5,242,118 shares
- Apple~$1.54BAdded · 0.3% → 0.6%+13,329,976 shares
- Comcast Corp New~$1.05BAdded · 2.4% → 3.0%+22,682,144 shares
- Honeywell Technologies~$910.7MAdded · 0.0% → 0.3%+5,532,444 shares
- Carrier Global~$846.3MAdded · 0.0% → 0.3%+27,710,616 shares
- Philip Morris Intl Inc~$686.9MAdded · 1.2% → 1.4%+9,160,675 shares
- Citizens Finl Group Inc~$609.5MNew · 0.0% → 0.2%+24,118,092 shares
- Centene Corp Del~$574.2MAdded · 0.3% → 0.4%+9,844,565 shares
- Crispr Therapeutics Ag~$572.2MAdded · 0.0% → 0.2%+6,841,159 shares
Largest sells
Since Q2 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amazon~$2.43BCut · 3.9% → 3.4%−771,789 shares
- Deere & Co~$1.16BCut · 0.4% → 0.2%−5,248,624 shares
- Activision Blizzard Inc~$1.03BCut · 1.1% → 0.8%−12,743,270 shares
- Humana Inc~$965.9MCut · 0.8% → 0.5%−2,334,202 shares
- Microsoft~$759.0MCut · 6.5% → 6.2%−3,608,698 shares
- Eli Lilly~$746.6MCut · 1.1% → 0.7%−5,044,616 shares
- Global Pmts Inc~$744.1MCut · 0.3% → 0.1%−4,190,408 shares
- Anthem Inc~$738.9MCut · 0.6% → 0.4%−2,751,913 shares
- Goldman Sachs~$690.1MCut · 0.3% → 0.1%−3,433,612 shares
- Cvs Health Corp~$664.1MCut · 0.5% → 0.2%−11,371,330 shares
Holdings
As of Sep 30, 2020. Changes are in shares against Jun 30, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −3.7% · price +3.4% | 6.2% | $19.90B | +$645.8M | ||||||||
| MetaCL A · shares −3.7% · price +15.3% | 4.0% | $13.04B | +$1.73B | ||||||||
| BroadcomCOM · shares −1.7% · price +15.4% | 3.9% | $12.54B | +$1.68B | ||||||||
| AmazonCOM · shares −18% · price +14.1% | 3.4% | $11.14B | +$1.38B | ||||||||
| Comcast Corp NewCL A · shares +12% · price +18.7% | 3.0% | $9.65B | +$1.35B | ||||||||
| NetflixCOM · shares +7.0% · price +9.9% | 2.5% | $8.10B | +$681.0M | ||||||||
| Charter Communications Inc NCL A · shares −0.5% · price +22.4% | 2.0% | $6.41B | +$1.17B | ||||||||
| Abbott LabsCOM · shares −1.3% · price +19.0% | 1.9% | $6.09B | +$973.7M | ||||||||
| AlphabetCAP STK CL C · shares −6.7% · price +4.0% | 1.8% | $5.98B | +$228.3M | ||||||||
| Unitedhealth Group IncCOM · shares −3.1% · price +5.7% | 1.7% | $5.63B | +$303.3M | ||||||||
| IntelCOM · shares −9.8% · price −13.4% | 1.6% | $5.17B | −$803.1M | ||||||||
| Northrop Grumman CorpCOM · shares −7.5% · price +2.6% | 1.5% | $4.76B | +$122.3M | ||||||||
| Philip Morris Intl IncCOM · shares +18% · price +7.0% | 1.4% | $4.53B | +$252.0M | ||||||||
| Visa Inc.COM CL A · shares −8.0% · price +3.5% | 1.3% | $4.12B | +$140.4M | ||||||||
| Seattle Genetics IncCOM · shares −0.3% · price +15.2% | 1.1% | $3.65B | +$480.4M | ||||||||
| Jpmorgan Chase & CoCOM · shares +7.3% · price +2.3% | 1.0% | $3.27B | +$70.0M | ||||||||
| Merck & Co. IncCOM · shares +6.0% · price +7.3% | 0.98% | $3.17B | +$202.5M | ||||||||
| Gilead Sciences IncCOM · shares −15% · price −17.9% | 0.95% | $3.07B | −$667.0M | ||||||||
| MastercardCL A · shares +149% · price +14.4% | 0.91% | $2.96B | +$149.0M | ||||||||
| TSMCSPONSORED ADS · shares −0.02% · price +42.8% | 0.91% | $2.95B | +$885.4M | ||||||||
| Truist Finl CorpCOM · shares −8.2% · price +1.3% | 0.89% | $2.87B | +$37.6M | ||||||||
| Johnson & JohnsonCOM · shares +0.09% · price +5.9% | 0.84% | $2.72B | +$150.5M | ||||||||
| Transdigm Group IncCOM · shares +9.9% · price +7.5% | 0.84% | $2.72B | +$172.2M | ||||||||
| Activision Blizzard IncCOM · shares −28% · price +6.7% | 0.82% | $2.64B | +$164.6M | ||||||||
| AlphabetCAP STK CL A · shares +0.06% · price +3.4% | 0.80% | $2.60B | +$84.4M | ||||||||
| Total · 435 positions | 100% | $323.46B | +$16.26B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2020 to Q3 2020: 394 stocks held throughout, up $16.26B (+5.8%).
- Meta+$1.73B+15%
- Broadcom+$1.68B+15%
- Amazon+$1.38B+14%
- Comcast Corp New+$1.35B+19%
- Charter Communications Inc N+$1.17B+22%
- Chevron Corp New−$502.4M−19%
- Gilead Sciences Inc−$667.0M−18%
- Eog Res Inc−$677.8M−29%
- Apple−$702.1M−68%
- Intel−$803.1M−13%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $483.61B+13% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $426.52B−33% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $637.97B+3% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $619.40B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $580.56B+14% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $508.52B−4% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $532.30B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $520.97B+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $485.73B−2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $493.90B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $446.09B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $394.11B−5% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $414.45B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $388.71B+4% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $372.54B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $342.83B−7% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $367.64B−16% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $438.61B−7% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $473.03B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $437.44B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $437.89B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $395.24B+8% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $366.38B+13% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $323.46B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $305.21B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $244.50B−17% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $294.42B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $261.94B+5% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $250.64B+8% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $232.80B+16% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $200.60B−8% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $218.36B+147% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $88.55B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $86.51B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $88.52B+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $83.48B+11% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $74.88B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $73.61B+6% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $69.28B+0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $68.95B+1% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $68.21B+5% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $65.22B | SEC ↗ |